rhinitis

Search with Google Search with Bing
Information
Disease name
rhinitis
Disease ID
DOID:4483
Description
"A upper respiratory infectious disease which involves irritation and inflammation of the mucous membrane of the nose due to viruses, bacteria or irritants. The inflammation results in generation of excessive amounts of mucus leading to runny nose, as well as nasal congestion and post-nasal drip." [url:http\://en.wikipedia.org/wiki/Rhinitis]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT06448585 Active, not recruiting Phase 4 Dietary Supplement (Beta-Glucans) in Allergic Patients Undergoing Subcutaneous Immunotherapy. May 20, 2024 January 20, 2025
NCT00200928 Completed N/A Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood. January 1999 July 2005
NCT00200954 Completed N/A Primary Prevention of Atopic Disease by Perinatal Administration of Probiotics January 2004 August 2008
NCT00279916 Completed Phase 3 Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays September 1, 2005 March 2009
NCT03311048 Completed N/A Airway Inflammatory Profile Among Cleaning Workers From Different Workplaces February 1, 2015 December 1, 2017
NCT01971086 Completed Treatment With Rhinospray Plus in Patients With Acute Rhinitis in the Everyday Curative Routine in Hungary October 2013 March 2014
NCT02272101 Completed Phase 3 Rhinitis in the Elderly: The Role of Vitamin D November 2013 March 2014
NCT02279706 Completed Korean Linguistic Adaptation of Rhinitis Controlled Assessment Test October 2014 October 2015
NCT02340130 Completed Phase 2 Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma September 2014 June 2018
NCT02360072 Completed Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma September 2014 September 2015
NCT02477293 Completed Phase 4 The Efficacy and Safety of Hyeonggaeyeongyo-tang for Chronic Rhinitis According to Pattern Identification in Korean Medicine August 2015 January 2016
NCT02478060 Completed Phase 2 Birch-SPIRE Safety and Efficacy Study July 2015
NCT02596321 Completed Phase 3 A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma October 2015 June 2016
NCT02654223 Completed Phase 2 Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy December 30, 2015 November 2021
NCT02763241 Completed Phase 3 Cleanoze® Irrigation Device With Powder Preparation Versus Conventional Irrigation Method for Chronic Rhinitis January 2016 January 2018
NCT02784262 Completed Phase 2 Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis October 2016 December 2018
NCT02820597 Completed N/A ClariFix Cryoablation Clinical Study June 15, 2015 July 20, 2016
NCT02879929 Completed Development and Validity of the DyNaChron Questionnaire for Chronic Nasal Dysfunction October 2005 December 2006
NCT03286049 Completed Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age January 10, 2018 July 31, 2018
NCT00078195 Completed Phase 2 Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies April 2003 May 2005
NCT03380715 Completed N/A A Comparison Between Co-phenylcaine Nasal Spray and Nasal Nebulization Prior to Rigid Nasoendoscopic Examination May 13, 2016 August 1, 2018
NCT03394508 Completed Phase 2/Phase 3 The Safety and Efficacy of Intralymphatic Immunotherapy in Pollen Allergic Adolescents and Young Adults With Asthma January 2013 December 2017
NCT03555890 Completed Phase 1 Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Release Tablet (IRT) May 18, 2018 September 17, 2018
NCT04132570 Completed Phase 4 A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne Pollution October 22, 2019 January 22, 2020
NCT04230993 Completed N/A Efficacy of Two Nasal Products for Decongestion and Mucus Fluidification December 24, 2019 June 20, 2020
NCT05960318 Completed Post Market Clinical Follow-Up Study - Medical Device KalobaNaso May 8, 2023 July 31, 2023
NCT05999955 Completed N/A Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis December 29, 2022 May 25, 2023
NCT00291642 Completed Phase 2 A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen January 1, 2006 April 1, 2006
NCT00355160 Completed Non-Rhinologic Etiologies of Headaches and Facial Pain in Tertiary Care Setting July 2006 April 2009
NCT00427479 Completed Oral Allergy Syndrome (OAS): a Pilot Study to Evaluate a Clinical Questionnaire as a Diagnostic Tool July 2002 December 2003
NCT00438646 Completed Oral Bacteria and Allergic Disease in Children February 2007
NCT00474890 Completed N/A Study to Compare the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Placebo on Symptoms in Patients With Allergic Rhinitis Within/Out of Season June 2007 February 2008
NCT00521131 Completed Phase 4 Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites September 2002 May 2003
NCT00524836 Completed Phase 3 Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis September 2003 February 2004
NCT00525278 Completed Phase 3 To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis August 2003 October 2003
NCT00541255 Completed A Long-Term Examination of Asthma From Childhood Through Adolescence September 2007 February 18, 2015
NCT00550550 Completed Phase 3 Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) November 2007 September 2009
NCT00562159 Completed Phase 3 Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) November 2007 September 2009
NCT00623701 Completed Phase 3 Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation March 2008 October 2012
NCT00630474 Completed Phase 4 Nasal Decongestion and Obstructive Sleep Apnea January 2004 April 2005
NCT00704496 Completed Phase 3 The Effect of Pseudoephedrine on Rhinitis and Sleep June 2007 September 2009
NCT00704769 Completed Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299) May 2005 December 2007
NCT00723736 Completed Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED) December 2007 June 2008
NCT00724698 Completed Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria October 2005 December 2007
NCT00731250 Completed Phase 1 A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge Model July 22, 2008 March 31, 2009
NCT00762567 Completed Phase 1 Phenylephrine Pediatric Pharmacokinetic Study September 2008 November 2008
NCT00822406 Completed Phase 4 Effectiveness of Individualized Homeopathic Treatment in Perennial Allergic Rhinitis July 2002 December 2006
NCT00831428 Completed Screening Scottish Swimmers for Asthma and Rhinitis February 2009 June 2009
NCT00857779 Completed Phase 2 Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients February 2009 October 2009
NCT00907933 Completed Phase 1 Intranasal SB-705498 in Healthy Volunteers November 10, 2008 February 11, 2009
NCT00963573 Completed Phase 4 Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428) September 2003 November 2006
NCT00978029 Completed Phase 2 Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081) November 2009 February 2010
NCT01030146 Completed N/A Management of Allergic Rhinitis Patients With Nasal Steroids and NeilMed® Sinus Rinse™ System With Isotonic Saline December 2009 June 2013
NCT01096615 Completed Phase 3 Effect Of Probiotic Lactobacillus Paracasei Lp-33 For The Management Of Rhinitis In People Sensitized To Allergens April 2010 September 2011
NCT01118312 Completed Phase 4 Study of Asthma and Nasal Steroids September 2010 June 2015
NCT01295866 Completed Evaluation Effects of Nasal Nitric Oxide Measurements Are Associated With Atopy Status in Chronic Nasal Inflammation January 2010 November 2010
NCT01330017 Completed Phase 2 Effects of Phenylephrine on Nasal Congestion in Participants With Seasonal Allergic Rhinitis (P08156 AM2)(Completed) March 2011 June 2011
NCT01376206 Completed Drug Use Investigation for ALLERMIST December 2009 May 2011
NCT01383941 Completed Asthma Phenotypes in the Inner City August 2011 September 2014
NCT01393548 Completed Phase 3 Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of Rhinitis August 2014 December 2016
NCT01393561 Completed Phase 3 Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of Rhinitis July 2014 December 2014
NCT01420822 Completed Special Drug Use Investigation for ALLERMIST (Long Term) December 2010 August 2014
NCT01424397 Completed Phase 2 Intranasal SB-705498 in Allergic Rhinitis (AR) Patients April 14, 2011 July 7, 2011
NCT01424514 Completed Phase 2 SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis December 1, 2010 April 18, 2011
NCT01439308 Completed Phase 2 Intranasal SB-705498 in Non-allergic Rhinitis Patients December 2009 May 2010
NCT01469234 Completed Phase 4 A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712) October 2011 November 2011
NCT01476098 Completed Phase 2 A Study to Investigate the Effect of SB-705498 on Chronic Cough April 2011 January 2012
NCT01563081 Completed Phase 3 Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics April 2012 August 2012
NCT01602237 Completed Preventing Respiratory Health Problems in Bakery Employees February 2012 December 2015
NCT01622231 Completed Phase 3 Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis June 2012 November 2012
NCT01651481 Completed Phase 1 Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination July 2012 December 2012
NCT01734265 Completed Phase 2 Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml). November 2012 April 2013
NCT01771120 Completed Control and Burden of Asthma and Rhinitis October 2012 September 2014
NCT01862523 Completed Phase 4 Mechanisms of Capsaicin Treatment in Idiopathic Rhinitis Patients and Controls February 2012 December 2014
NCT01875276 Completed Evaluating the Need for New Rhinitis Treatment January 2013 March 2013
NCT06350448 Not yet recruiting N/A Washed Microbiota Transplantation for Rhinitis May 1, 2024 August 1, 2029
NCT04012216 Recruiting Sleep Respiratory Disorders in Patients With Moderate to Severe Persistent Rhinitis January 28, 2020 July 31, 2025
NCT06291402 Recruiting Nasal Packing Duration and Development of Pharyngitis After Septorhinoplasty Surgery March 10, 2024 June 15, 2024
NCT00967967 Suspended N/A Validation of the Rhinitis Control Scoring System (RCSS) March 2009 September 2014
NCT00281307 Terminated N/A Treatment of Rhinitis With Intranasal Vitamin E December 7, 2005 September 1, 2007
NCT00144443 Terminated N/A Kansas City Community Environmental Remediation And Training (KC CERT) March 2003 May 2005
NCT00295737 Terminated N/A Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent Asthma February 2006 January 2008
NCT00344942 Terminated Phase 3 Efficacy and Safety Study of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults April 2006
NCT02630472 Terminated Phase 1/Phase 2 Topical Irrigation Therapy for CRS October 2015 May 4, 2017
NCT01008592 Terminated The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism April 2009 September 2010
NCT02758990 Terminated N/A Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application March 2016 November 23, 2016
NCT01248325 Unknown status Phase 3 A Study of Luffa Operculate Nasal Solution 5mg/mL Compared With Saline (NaCl 09%) for the Relief of Nasal Obstruction January 2011 July 2011
NCT03952845 Unknown status Phase 1 Intranasal Capsaicinoid Spray July 1, 2019 December 1, 2022
NCT00952835 Unknown status Evaluation of Different Disease Control Indices in Children With Asthma and Rhinitis July 2009 December 2014
NCT00406094 Unknown status Phase 4 Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES) November 2006 December 2009
NCT02661854 Unknown status Phase 2 Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy June 21, 2016 July 2020
NCT01085916 Unknown status Prevalence of Asthma and Rhinitis Symptoms Among Secondary School Students in Saudi Arabia April 2010 May 2010
NCT01564849 Unknown status The Clinical Efficacy of Topical Nasal Pomegranate Fruit Extract for Patients With Chronic Rhinosinusitis April 2012 February 2017
NCT02278081 Unknown status Phase 4 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate January 2015 January 2017
NCT02949050 Unknown status N/A Corn Occupational Rhinitis SCIT Efficacy Study August 2016 December 2018
NCT02795273 Withdrawn Phase 2/Phase 3 Efficacy and Safety of Grass-SPIRE Registration Study May 2016
NCT01177852 Withdrawn Phase 3 Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis October 2011
Disase is a (Disease Ontology)
DOID:2163
Cross Reference ID (Disease Ontology)
MESH:D012220
Cross Reference ID (Disease Ontology)
NCI:C34986
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:70076002
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0035455
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0012384
MedGen concept unique identifier (MedGen Concept name)
C0035455
MedGen unique identifier (MedGen Concept name)
19782
MeSH unique ID (MeSH (Medical Subject Headings))
D012220